Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment Alternatives in Adult Rare Disease; Assessment of Options in Idiopathic Subglottic Stenosis North American Airway Collaborative PR-02 Study (NoAAC PR-02 Study)

NCT02481817 is registered in ClinicalTrials.gov with Vanderbilt University Medical Center as lead sponsor.

NCT NCT02481817
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02481817 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment Alternatives in Adult Rare Disease; Assessment of Options in Idiopathic Subglottic Stenosis North American Airway Collaborative PR-02 Study (NoAAC PR-02 Study)
Lead sponsor
Vanderbilt University Medical Center
Phase
Observational
Overall status
Completed
Start date
August 28, 2015
Completion date
September 10, 2020
Enrollment
1,239 (actual)
Sites
42

Conditions

As the registry lists them; a condition with its own page is linked.

idiopathic subglottic stenosis (isgs)